Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hulsman

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Science Translational Medicine|December 3, 2025
Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer's diseaseTanya N Weerakkody, Hanna Sabelström, Shan V Andrews, et al.
Acta Neuropathologica|March 14, 2020
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairmentLuca Kleineidam, Vincent Chouraki, Tomasz Próchnicki, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Non-microglial downregulation of <i>PLCG2</i> impairs synaptic function and elicits Alzheimer disease-related hallmarksAudrey Coulon, Florian Rabiller, Mari Takalo, et al.
European Journal of Human Genetics : EJHG|May 16, 2025
A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASCPablo García-González, Héctor Rodrigo Lara, Yaroslau Compta, et al.
Nature Communications|July 21, 2025
Machine learning in Alzheimer's disease geneticsMatthew Bracher-Smith, Federico Melograna, Brittany Ulm, et al.
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Acta Neuropathologica|January 20, 2020
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Molecular Neurodegeneration|December 2, 2025
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's diseaseOlav M Andersen, Matthijs W J de Waal, Giulia Monti, et al.
Acta Neuropathologica|May 28, 2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Science Translational Medicine|December 3, 2025
Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer's diseaseTanya N Weerakkody, Hanna Sabelström, Shan V Andrews, et al.
Acta Neuropathologica|March 14, 2020
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairmentLuca Kleineidam, Vincent Chouraki, Tomasz Próchnicki, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Non-microglial downregulation of <i>PLCG2</i> impairs synaptic function and elicits Alzheimer disease-related hallmarksAudrey Coulon, Florian Rabiller, Mari Takalo, et al.
European Journal of Human Genetics : EJHG|May 16, 2025
A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASCPablo García-González, Héctor Rodrigo Lara, Yaroslau Compta, et al.
Nature Communications|July 21, 2025
Machine learning in Alzheimer's disease geneticsMatthew Bracher-Smith, Federico Melograna, Brittany Ulm, et al.
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Acta Neuropathologica|January 20, 2020
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Molecular Neurodegeneration|December 2, 2025
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's diseaseOlav M Andersen, Matthijs W J de Waal, Giulia Monti, et al.
Acta Neuropathologica|May 28, 2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Pageof 8